Prospera Financial Services Inc Acquires 61,260 Shares of Lam Research Corporation $LRCX

Prospera Financial Services Inc grew its holdings in Lam Research Corporation (NASDAQ:LRCX) by 620.5% during the second quarter, Holdings Channel.com reports. The firm owned 71,133 shares of the semiconductor company’s stock after acquiring an additional 61,260 shares during the period. Prospera Financial Services Inc’s holdings in Lam Research were worth $6,926,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in LRCX. Vanguard Group Inc. raised its holdings in shares of Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after buying an additional 8,364,375 shares during the last quarter. Nuveen LLC acquired a new stake in Lam Research in the 1st quarter valued at about $604,344,000. Price T Rowe Associates Inc. MD increased its position in Lam Research by 99.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock valued at $417,242,000 after acquiring an additional 2,864,863 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of Lam Research by 34.1% in the second quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock worth $1,029,210,000 after acquiring an additional 2,692,189 shares during the last quarter. Finally, Boston Partners lifted its position in shares of Lam Research by 9,978.3% during the first quarter. Boston Partners now owns 2,350,362 shares of the semiconductor company’s stock worth $170,787,000 after purchasing an additional 2,327,041 shares in the last quarter. Institutional investors own 84.61% of the company’s stock.

Wall Street Analysts Forecast Growth

LRCX has been the topic of several research analyst reports. Mizuho increased their price target on shares of Lam Research from $162.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Argus upped their price objective on Lam Research from $105.00 to $120.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Barclays set a $142.00 target price on Lam Research and gave the company an “equal weight” rating in a research note on Monday, October 20th. Weiss Ratings restated a “buy (b-)” rating on shares of Lam Research in a research report on Wednesday. Finally, KeyCorp raised their price target on Lam Research from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $148.54.

Insider Activity at Lam Research

In other Lam Research news, insider Ava Harter sold 9,010 shares of the stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares in the company, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 62,498 shares of company stock worth $8,875,663 in the last ninety days. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

LRCX stock opened at $159.35 on Friday. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $166.92. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The company has a market cap of $200.15 billion, a P/E ratio of 35.10, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The business’s fifty day moving average is $134.94 and its 200-day moving average is $106.61.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the previous year, the firm earned $0.86 earnings per share. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.